Mean changes in the personal and social performance total score in the negative symptom group. Abbreviations: LO last observation, PSP personal and social performance, W52 Week 52
Description
Efficacy outcomes measured by PANSS total score changes from baseline are compared across bitopertin dose groups and placebo over the 52-week study period.
Fig. 3
ChartSource Paper
A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese …Cite This Figure
 > Source: Yoshio Hirayasu et al. "A double-blind randomized study assessing safety and efficacy following one-year." *BMC psychiatry*, 2016. PMID: [26980460](https://pubmed.ncbi.nlm.nih.gov/26980460/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791769/bin/12888_2016_778_Fig3_HTML.jpg" alt="Efficacy outcomes measured by PANSS total score changes from baseline are compared across bitopertin dose groups and placebo over the 52-week study period." /> <figcaption>Fig. 3. Efficacy outcomes measured by PANSS total score changes from baseline are compared across bitopertin dose groups and placebo over the 52-week study period.<br> Source: Yoshio Hirayasu et al. "A double-blind randomized study assessing safety and efficacy following one-year." <em>BMC psychiatry</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/26980460/">26980460</a></figcaption> </figure>